Rather Than Give Away Its COVID Vaccine, Oxford Makes a Deal With Drugmaker
(By Jay Hancock for Kaiser Health News) In a business driven by profit, vaccines have a problem. They’re not very
Read More(By Jay Hancock for Kaiser Health News) In a business driven by profit, vaccines have a problem. They’re not very
Read More(By Maia Anderson for Becker’s Hospital Review) At least five drugmakers have told hospitals in recent weeks that they won’t
Read MoreHumira, biologic drug that is used to treat inflammatory conditions, is mainly covered by Medicare Part D and Part C;
Read MoreAccording to a report from MedicareAdvantage.com, it found Medicare spent more than $1.4 billion on discarded drugs during 2017 and
Read MoreIf you are approaching 65, you have a very important decision to make: Do you sign up for Medicare? Is
Read More(By Maia Anderson for Becker’s Hospital Review) The U.S. government is working with commercial health insurers to make future COVID-19 vaccines
Read More(By Mackenzie Bean for Becker’s Hospital Review) Federal health officials and drugmakers are taking several steps to boost flu vaccinations this
Read MoreAn estimated $98 billion in Medicare Part D prescription drug spending in 2019, plan sponsors can affect overall retail drug
Read MoreMedicare Part D is available through private insurance providers and can be used for prescription drug coverage. The different plans
Read More(By Katie Adams for Becker’s Hospital Review) States that implemented out-of-pocket price caps for expensive specialty drugs saw patient spending
Read More